Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION (RAD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH -0.37% 65.12 Delayed Quote.-9.16%
RITE AID CORPORATION -1.25% 1.58 Delayed Quote.-18.78%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
04/20RITE AID : closing Market Street store
AQ
04/19RITE AID CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/19RITE AID : Commences Offer to Purchase Certain of its Outstanding Series of Note..
BU
04/19RITE AID : Naloxone Available at Rite Aid Pharmacies in 19 States
BU
04/18RITE AID CORP : Regulation FD Disclosure (form 8-K)
AQ
04/18RITE AID : What's the deal with Rite-Aid?
AQ
04/18RITE AID : 1 arrested after deadly Gentilly shootout pit man against girlfriend'..
AQ
04/17Amex to end Plenti loyalty program in July
AQ
04/17RITE AID : Police searching for Rite Aid robber who took pills
AQ
04/17RITE AID : Suspected robber arrested in April 4 Kenmore drug store holdup
AQ
More news
News from SeekingAlpha
04/19Rite-Aid launches offer to buy up to $700M of senior debt; shares up 1% after.. 
04/19Rite Aid's Merger Still Makes Sense 
04/16After Shareholder Backlash, Rite Aid-Albertsons Deal May Get Renegotiated 
04/13RITE AID : Good News Overlooked 
04/13Pushback builds against Rite Aid-Albertsons deal 
Financials ($)
Sales 2019 21 645 M
EBIT 2019 208 M
Net income 2019 -36,9 M
Debt 2019 2 221 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 21,07
EV / Sales 2019 0,18x
EV / Sales 2020 0,17x
Capitalization 1 687 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 2,00 $
Spread / Average Target 27%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kermit R. Crawford President & Chief Operating Officer
Bryan B. Everett Chief Operating Officer-Rite Aid Stores
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Steve Rempel Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-18.78%1 687
RAIA DROGASIL-24.42%6 614
PALTAC CORP3.63%3 206
GALENICA AG4.10%2 670
AIN HOLDINGS INC17.51%2 606
SOGO MEDICAL CO LTD-50.41%852